(Q46636181)

English

The expression of DeltaNTP73, TATP73 and TP53 genes in acute myeloid leukaemia is associated with recurrent cytogenetic abnormalities and in vitro susceptibility to cytarabine cytotoxicity

scientific article published on 17 April 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18422993

The expression of DeltaNTP73, TATP73 and TP53 genes in acute myeloid leukaemia is associated with recurrent cytogenetic abnormalities and in vitro susceptibility to cytarabine cytotoxicity (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18422993

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Eduardo Magalhães Rego

10

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18422993

Rodrigo A Panepucci

object named as

Rodrigo A Panepucci

2

0 references

Roberto P Falcão

object named as

Roberto P Falcão

9

0 references

author name string

Antonio R Lucena-Araujo

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18422993

Guilherme A S dos Santos

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18422993

Rafael H Jácomo

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18422993

Bárbara A A Santana-Lemos

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18422993

Ana S G Lima

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18422993

Aglair B Garcia

7

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18422993

Amélia G Araújo

8

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18422993

language of work or name

0 references

publication date

17 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18422993

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18422993

142

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18422993

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18422993

74-78

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18422993

Ubiquitin-dependent degradation of p73 is inhibited by PML.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07160.X

21 January 2018

Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07160.X

21 January 2018

Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07160.X

21 January 2018

deltaN-p73 is a transcriptional target of the PML/RARalpha oncogene in myeloid differentiation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07160.X

21 January 2018

Cytogenetic and morphological findings in 166 patients with de novo acute myeloid leukemia in southern Brazil.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07160.X

21 January 2018

RETRACTED: Alteration of p73 in acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07160.X

21 January 2018

Role of p73 in malignancy: tumor suppressor or oncogene?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07160.X

21 January 2018

p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07160.X

21 January 2018

DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07160.X

21 January 2018

Identifiers

10.1111/J.1365-2141.2008.07160.X

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18422993

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18422993

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46636181&oldid=2123571558"